Outcomes of Neonatal Acute Kidney Injury In Premature Infants
1 other identifier
observational
25
1 country
1
Brief Summary
The objective of this protocol is to investigate the impact of prematurity, with or without associated acute kidney injury (AKI), on the future risk of chronic kidney disease (CKD) by establishing a patient registry and biorepository. Serum and urine samples will be collected serially from premature infants admitted to the neonatal intensive care unit (NICU) at Albert Einstein College of Medicine/Weiler Hospital and subsequently followed in the NICU follow-up and pediatric nephrology ambulatory subspecialty clinics. The biorepository will be linked to a comprehensive clinical database.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 19, 2015
CompletedFirst Posted
Study publicly available on registry
March 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedSeptember 19, 2024
September 1, 2024
9.8 years
February 19, 2015
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Chronic kidney disease (incidence of chronic renal insufficiency in childhood)
Determine the incidence of chronic renal insufficiency in childhood
5 years
Secondary Outcomes (3)
Acute kidney injury (incidence of acute kidney injury in preterm infants)
0-5 months
Assessment of serum biomarkers - cystatin C
0 months - 5 years
Assessment of urinary biomarkers - urinary neutrophil gelatinase-associated lipocalin, interlukin 18 and kidney-injury molecule-1
0 months - 5 years
Study Arms (1)
Preterm infants
Less than 32 weeks' gestation
Interventions
Eligibility Criteria
Preterm infants less than 32 weeks' gestational age
You may qualify if:
- Preterm infants less than 32 weeks/ gestational age admitted to the Neonatal Intensive Care Unit at Weiler Hospital (The Children's Hospital at Montefiore).
You may not qualify if:
- Known major congenital anomalies of the kidney and urinary tract (CAKUT) including solitary kidney, cystic dysplasia, multicystic dysplastic kidney, renal hypoplasia, obstructive uropathy
- Other genetic syndromes or medical conditions that preclude enrollment per judgment of the attending neonatologist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jack D. Weiler Hospital
The Bronx, New York, 10461, United States
Biospecimen
Blood and urine samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mamta Fuloria, MD
The Children's Hospital at Montefiore, Albert Einstein College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2015
First Posted
March 3, 2015
Study Start
November 1, 2014
Primary Completion
August 30, 2024
Study Completion
August 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share